表柔比星用于晚期结直肠癌且未接受过化疗患者的II期研究：伊利诺伊州癌症协会试验 - Suppr

Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.

Locker G Y, Hoeltgen T, Kilton L, Krauss S, McNamara M, Blough R, Johnson C

Cancer Treat Rep. 1987 Jul-Aug;71(7-8):765-6.

Abstract

摘要

Cancer Treat Rep. 1987 Jul-Aug;71(7-8):765-6.

Cancer Treat Rep. 1986 Oct;70(10):1241-2.

Cancer Treat Rep. 1987 Jun;71(6):649-50.

Cancer Treat Rep. 1985 Jan;69(1):143-4.

Cancer Treat Rep. 1987 Sep;71(9):871-2.

Cancer Treat Rep. 1986 Feb;70(2):307-8.

Cancer Treat Rep. 1984 Oct;68(10):1303-4.

Cancer Treat Rep. 1979 Jan;63(1):139-40.

Cancer Treat Rep. 1987 Jun;71(6):663-4.

Cancer Treat Rep. 1983 Mar;67(3):307-8.

Invest New Drugs. 1989 Jul;7(2-3):235-8. doi: 10.1007/BF00170865.

Invest New Drugs. 1989 Nov;7(4):333-6. doi: 10.1007/BF00173763.

Invest New Drugs. 1991 Feb;9(1):83-5. doi: 10.1007/BF00194552.

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。